© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Clarithromycin belongs to the macrolide class of antibiotics, often used to manage a range of bacterial infections. Its molecular formula, C38H69NO13, gives a sense of its complexity. Many pharmacists and chemists know it for its broad antibacterial activity and reliability in clinical settings. Most patients come across this active ingredient in solid, powder, or crystalline form, often as pale, somewhat waxy flakes or as a more refined powder. Molecular mass lands at 747.96 g/mol, marking it as a relatively large molecule among common antibiotics. It possesses an HS Code typically referenced as 29415090 in global trade, simplifying its identification in pharmaceutical supply chains and customs processes.
Working with raw materials like Clarithromycin, one quickly notices its white to off-white appearance, showing up as fine crystals or as a finely milled powder. The solid exhibits low solubility in water but dissolves more readily in methanol, chloroform, and acetone, making it useful across a spectrum of chemical processes. With a melting point measured at around 225°C (decomposition), it holds up in a range of manufacturing environments without losing its integrity. As for density, the average bulk density lands near 0.3–0.4 g/cm³, a useful figure for pharmacists dosing powders and blending compounds in bulk. Unlike simple salts or inorganic chemicals, clarithromycin’s macrolide ring structure carries multiple chiral centers, hydroxyl groups, and deoxy sugars. Each of these features impacts its binding to bacterial ribosomes and drives its medical effectiveness.
Those who process large amounts of this compound know that clarithromycin arrives mainly as a semi-solid or as compressed flakes, sometimes shaped into pearls or standard tablets. As a raw material, it comes stabilized in specially lined drums or moisture-resistant packs, protecting its somewhat hygroscopic nature. Exposure to high humidity can affect quality and texture, so experienced manufacturers take care with storage conditions. It isn’t volatile at room temperature but does emit a faint odor typical of antibiotics, which seasoned lab workers learn to recognize quickly. In the lab or production setting, clarithromycin can be suspended or dissolved to form solutions, often at concentrations tailored to the needs of the application. Keeping it as a uniform powder helps avoid inaccurate dosing, a concern that hospital and pharmacy professionals face regularly.
Handling clarithromycin involves paying attention to its safety profile. Classified as harmful if swallowed in large quantities or through prolonged exposure, operators wear gloves and masks when mixing or packaging large batches. Its dust can cause mild respiratory irritation, so localized ventilation and personal protective equipment are standard practice. As a chemical agent, clarithromycin doesn’t fall under the most hazardous raw materials, but its impact on aquatic environments deserves a close look; improper disposal into water systems risks creating drug-resistant bacteria—a problem that countries are only beginning to address in earnest. This reality underscores the importance of proper waste handling procedures, including incineration or safe chemical breakdown, for any facility working with antibiotics. The push for “greener” pharmaceutical production highlights the need for waste-control technologies and clear regulatory guidelines.
Examining clarithromycin under a microscope or in a spectroscopy suite, chemists spot the 14-membered lactone ring, two sugar residues (cladinose and desosamine), and a methoxy group at C6—distinguishing it from similar compounds like erythromycin. Spectroscopic data, including IR and NMR readings, confirm its purity and help catch any unwanted isomers or degradation products. Material specifications supplied to hospitals and pharmacies include not just assay results, but also impurity profiles and moisture content figures, often below 3% to keep activity high. In my experience, laboratories spend as much time validating the structure as preparing the active ingredient, since accuracy prevents costly treatment failures and ensures patient safety on a large scale.
Supplying clarithromycin in bulk involves navigating a complicated set of regulations and documentation requirements, from the aforementioned HS Code to detailed batch records. Material traceability, from synthetic starting materials to final crystal, supports both patient safety and product recalls if needed. The density, melting point, and solubility data each serve as quick reference points, allowing manufacturers to catch processing errors before they become major risks. As the global market demands stable, high-grade pharmaceutical ingredients, attention to these chemical and physical properties keeps shipments reliable and complaints to a minimum. Supply chain partners benefit from clear labeling, robust hazard data, and consistent quality—all rooted in a deep understanding of clarithromycin’s unique properties.
Years of experience handling raw materials have taught many in the pharmaceutical industry that safety, efficacy, and traceability begin at the chemical property level. Solutions involve rigorous application of Good Manufacturing Practices (GMP), investment in analytical equipment, and ongoing professional education about safe handling. Policymakers need to keep pushing for stronger oversight, not just for end-user safety but also to minimize the risk of environmental contamination. Researchers who develop better ways to purify, recycle, or neutralize antibiotic byproducts will play a key part in this progress. Open communication among chemical suppliers, healthcare providers, and environmental agencies promises safer, more sustainable use of important materials like clarithromycin, from the lab bench all the way to patient care.
